Mark Yates
Mark Yates
Clinical Research Fellow, King's College London
Adresse e-mail validée de kcl.ac.uk
Titre
Citée par
Citée par
Année
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.
JB Galloway, S Norton, RD Barker, A Brookes, I Carey, BD Clarke, R Jina, ...
Journal of Infection, 2020
392020
Superresolution imaging of the cytoplasmic phosphatase PTPN22 links integrin-mediated T cell adhesion with autoimmunity
GL Burn, GH Cornish, K Potrzebowska, M Samuelsson, J Griffié, ...
Science signaling 9 (448), ra99-ra99, 2016
272016
The new entries in the therapeutic armamentarium: the small molecule JAK inhibitors
K Bechman, M Yates, JB Galloway
Pharmacological research 147, 104392, 2019
242019
Rising Incidence of Acute Hospital Admissions due to Gout
MD Russell, M Yates, K Bechman, AI Rutherford, S Subesinghe, ...
The Journal of Rheumatology 47 (4), 619-623, 2020
62020
Placebo response in rheumatoid arthritis clinical trials
K Bechman, M Yates, S Norton, AP Cope, JB Galloway
The Journal of Rheumatology 47 (1), 28-34, 2020
52020
Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
K Bechman, BD Clarke, AI Rutherford, M Yates, E Nikiphorou, M Molokhia, ...
Rheumatology 58 (10), 1767-1776, 2019
52019
Hydroxychloroquine use: the potential impact of new ocular screening guidelines
M Yates, R Malaiya, J Stack, JB Galloway
Eye 32 (1), 161-162, 2018
52018
Variation and implications of treatment decisions in early rheumatoid arthritis: results from a nationwide cohort study
M Yates, AJ MacGregor, J Ledingham, S Norton, K Bechman, ...
Rheumatology 59 (8), 2035-2042, 2020
32020
Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for …
K Bechman, A Oke, M Yates, S Norton, E Dennison, AP Cope, ...
Rheumatology, 2020
32020
Is Background Methotrexate Still Advantageous in Extending TNF Drug Survival in the Elderly: An Analysis of the British Society for Rheumatology Biologics Register-Rheumatoid …
K Bechman, A Oke, M Yates, S Norton, E Denderson, A Cope, J Galloway
ARTHRITIS & RHEUMATOLOGY 71, 2019
32019
How achievable are COVID-19 clinical trial recruitment targets? A UK observational cohort study and trials registry analysis
NG Cunniffe, SJ Gunter, M Brown, SW Burge, C Coyle, A De Soyza, ...
BMJ open 10 (10), e044566, 2020
22020
The use of real-world data to address questions of patient safety
M Yates, K Bechman, J Galloway
Rheumatology 59 (1), 26-30, 2020
12020
Centre effects and case-mix in early rheumatoid arthritis observational cohorts: a narrative review
M Yates, K Bechman, S Norton, E Nikiphorou, J Galloway
Rheumatology 58 (11), 1991-1999, 2019
12019
230 Liver function abnormalities on conventional DMARDs: results from a contemporary cohort
K Bechman, AI Rutherford, S Subesinghe, MD Russell, M Yates, S Norton, ...
Rheumatology 57 (suppl_3), key075. 454, 2018
12018
O06 Hydroxychloroquine use, risk of retinal toxicity, and potential impact of screening in a large tertiary centre
M Yates, K Bechman, S Subesinghe, A Rutherford, M Russell, R Malaiya, ...
Rheumatology 57 (suppl_3), key075. 188, 2018
12018
O04 Return of the king: rising incidence of gout in England 2006-2017 (Young investigator award winner 2018)
MD Russell, M Yates, AI Rutherford, S Subesinghe, K Bechman, ...
Rheumatology 57 (suppl_3), key075. 186, 2018
12018
Data quality predicts care quality: findings from a national clinical audit
M Yates, K Bechman, EM Dennison, AJ MacGregor, J Ledingham, ...
Arthritis Research & Therapy 22, 1-8, 2020
2020
Venous thromboembolism risk with JAK inhibitors: A Meta‐analysis
M Yates, A Mootoo, M Adas, K Bechman, S Rampes, V Patel, S Qureshi, ...
Arthritis & Rheumatology, 2020
2020
NEIAA: driving EIA service quality in a shifting clinical landscape
JM Ledingham, M Yates, JB Galloway
Rheumatology 59 (11), 3127-3128, 2020
2020
Corrigendum to: Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British …
K Bechman, A Oke, M Yates, S Norton, E Dennison, AP Cope, ...
Rheumatology, 2020
2020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20